{"publication":{"id":15073972,"resourceId":"16842460","title":"Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease.","sameAs":"https://www.ncbi.nlm.nih.gov/pubmed/16842460","type":"article"},"related":{"GENE":[{"objCls":"Gene","id":"PA356","symbol":"TPMT","name":"thiopurine S-methyltransferase"}],"DISEASE":[{"objCls":"Disease","id":"PA446116","name":"Inflammatory Bowel Diseases"}],"CHEMICAL":[{"objCls":"Chemical","id":"PA448515","name":"azathioprine"},{"objCls":"Chemical","id":"PA450379","name":"mercaptopurine"},{"objCls":"Chemical","id":"PA452634","name":"purine analogues"}]},"relationships":[{"id":1184168513,"literature":[{"id":15073972,"resourceId":"16842460","title":"Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease.","sameAs":"https://www.ncbi.nlm.nih.gov/pubmed/16842460","type":"article"}],"object1s":[{"objCls":"Gene","id":"PA356","symbol":"TPMT","name":"thiopurine S-methyltransferase"}],"object2s":[{"objCls":"Chemical","id":"PA448515","name":"azathioprine"}],"operator1":"and","operator2":"and","related":true,"terms":[{"id":769229935,"resource":"Phenotype Categories","term":"toxicity","termId":"secondaryCat:769229935"}]},{"id":1184168510,"literature":[{"id":15073972,"resourceId":"16842460","title":"Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease.","sameAs":"https://www.ncbi.nlm.nih.gov/pubmed/16842460","type":"article"}],"object1s":[{"objCls":"Gene","id":"PA356","symbol":"TPMT","name":"thiopurine S-methyltransferase"}],"object2s":[{"objCls":"Chemical","id":"PA452634","name":"purine analogues"}],"operator1":"and","operator2":"and","related":true,"terms":[{"id":769229935,"resource":"Phenotype Categories","term":"toxicity","termId":"secondaryCat:769229935"}]},{"id":1184168517,"literature":[{"id":15073972,"resourceId":"16842460","title":"Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease.","sameAs":"https://www.ncbi.nlm.nih.gov/pubmed/16842460","type":"article"}],"object1s":[{"objCls":"Chemical","id":"PA450379","name":"mercaptopurine"}],"object2s":[{"objCls":"Disease","id":"PA446116","name":"Inflammatory Bowel Diseases"}],"operator1":"and","operator2":"and","related":true,"terms":[{"id":769229935,"resource":"Phenotype Categories","term":"toxicity","termId":"secondaryCat:769229935"}]},{"id":1184168514,"literature":[{"id":15073972,"resourceId":"16842460","title":"Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease.","sameAs":"https://www.ncbi.nlm.nih.gov/pubmed/16842460","type":"article"}],"object1s":[{"objCls":"Disease","id":"PA446116","name":"Inflammatory Bowel Diseases"}],"object2s":[{"objCls":"Chemical","id":"PA448515","name":"azathioprine"}],"operator1":"and","operator2":"and","related":true,"terms":[{"id":769229935,"resource":"Phenotype Categories","term":"toxicity","termId":"secondaryCat:769229935"}]}]}